Get started
Author

Jonathan Steinfeld

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
2017 · Michael E. Wechsler, Praveen Akuthota, et al. · New England Journal of Medicine · 1,091
PDF
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
2020 · Florence Roufosse, Jean-Emmanuel Kahn, et al. · Journal of Allergy and Clinical Immunology · 223
PDF
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis
2018 · Jonathan Steinfeld, Eric S. Bradford, et al. · Journal of Allergy and Clinical Immunology · 151
From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases
2021 · Ian D. Pavord, Elisabeth H. Bel, et al. · Allergy · 115
PDF
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype
2019 · Atul Gupta, Masanori Ikeda, et al. · Journal of Allergy and Clinical Immunology · 107
Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma
2019 · Atul Gupta, Isabelle Pouliquen, et al. · Pediatric Pulmonology · 98
Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome
2018 · Fei Li Kuang, Michael P. Fay, et al. · The Journal of Allergy and Clinical Immunology In Practice · 94
Primary Ciliary Dyskinesia (Immotile Cilia Syndrome—Kartagener Syndrome)
2005 · DANIEL V. SCHIDLOW, JONATHAN STEINFELD · Elsevier eBooks · 92
Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review
2022 · Gema Requena, Judith van den Bosch, et al. · The Journal of Allergy and Clinical Immunology In Practice · 72
PDF
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
2021 · Gerald J. Gleich, Florence Roufosse, et al. · The Journal of Allergy and Clinical Immunology In Practice · 46
PDF
Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD)
2018 · Paneez Khoury, Praveen Akuthota, et al. · Journal of Leukocyte Biology · 44
HES and EGPA
2023 · Paneez Khoury, Praveen Akuthota, et al. · Mayo Clinic Proceedings · 41
PDF
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
2023 · Benjamin Terrier, David R.W. Jayne, et al. · ACR Open Rheumatology · 34
PDF
Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis
2020 · Lynn D. Condreay, Laura R. Parham, et al. · Rheumatology International · 29
PDF
Prevalence of Eosinophilic Granulomatosis With Polyangiitis and Associated Health Care Utilization Among Patients With Concomitant Asthma in US Commercial Claims Database
2019 · Mugdha Gokhale, Christopher F. Bell, et al. · JCR Journal of Clinical Rheumatology · 27
LEAP: A randomized–controlled trial of a lay-educator inpatient asthma education program
2015 · Jessica L. Rice, Kristen M. Matlack, et al. · Patient Education and Counseling · 27
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
2021 · Gema Requena, John Logie, et al. · Immunity Inflammation and Disease · 24
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
2022 · Marc E. Rothenberg, Florence Roufosse, et al. · The Journal of Allergy and Clinical Immunology In Practice · 23
PDF
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics
2023 · David R.W. Jayne, Benjamin Terrier, et al. · ERJ Open Research · 22
PDF
Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool
2020 · Nicholas Kovacs, Katy Benjamin, et al. · The Journal of Allergy and Clinical Immunology In Practice · 17
Congenital Pulmonary Lymphangiectasia
2004 · Jonathan Finder, Jonathan Steinfeld · New England Journal of Medicine · 16
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
2023 · Florence Roufosse, Joseph Butterfield, et al. · Frontiers in Medicine · 12
PDF
Mepolizumab for severe eosinophilic asthma: a comparison of efficacy in children, adolescents, and adults
2018 · Atul Gupta, Jonathan Steinfeld, et al. · 11
Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma
2016 · David S. Miller, Gloria Yiu, et al. · Allergy and Asthma Proceedings · 11
Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids
2016 · Edward M. Kerwin, Michael Gillespie, et al. · Journal of Asthma · 9
Works count: 67
Citation count: 2,528
H-index: 19
I10-index: 24
Year
Topic
Type